RBC downgrades Caribou Biosciences to Sector Perform
RBC Capital cut Caribou Biosciences to Sector Perform and set a $1.00 price target, implying 11.9% downside versus the Oct. 6 close of $1.14.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
RBC Capital Mkts downgrades Caribou Biosciences to Sector Perform
RBC Capital Markets downgraded Caribou Biosciences (CRBU) to a Sector Perform rating and set a $1 price target, from an Outperform rating.